Indonesia has suspended distribution of a batch of AstraZeneca PLC’s novel coronavirus vaccine to run tests for sterility and toxicity following the death of a 22-year-old man a day after immunization, the health ministry said on Sunday.
The “CTMAV547” batch consists of 448,480 vaccine doses that arrived in the Southeast Asian nation last month - part of a delivery of more than 3.85 million doses from the COVAX Facility, backed by the World Health Organization.
Some of the doses have been distributed in the capital city Jakarta and the province of North Sulawesi, as well as given to the military, the ministry said in a statement.
A national committee in charge of monitoring effects of novel coronavirus vaccination launched an investigation earlier this month after a 22-year-old man in Jakarta died a day after receiving an AstraZeneca shot.
The man received his dose from the CTMAV547 batch, health ministry spokeswoman Siti Nadia Tarmizi told Reuters.
“This is a form of caution by the government to ensure the safety of this vaccine,” she said in a statement, adding that distribution of other batches of AstraZeneca vaccines will not be affected.
The batch test could take at least two weeks, said the head of the vaccine monitoring committee, Hindra Irawan Satari.
“After it is proven that it is sterile and does not contain toxins, the use of the vaccine will be resumed. The fastest we can get the results will be in two weeks,” he said.
An AstraZeneca representative could not immediately comment.
Since the start of the pandemic early last year, Indonesia has recorded around 1.74 million cases of infection of the novel coronavirus that causes the potentially fatal COVID-19 respiratory disease. The country’s death toll stands at 47,967.
The government has been pushing to accelerate its vaccination program to control the spread of the virus. Official data showed that as of Saturday, nearly 9 million people have been fully vaccinated.
Indonesia to restrict foreign travelers coming from India amid COVID-19 surgeIndonesia will stop issuing visas for foreigners who have been in India in the past 14 days to prevent the spread of different coronavirus strains, ... Coronavirus
Indonesia halts COVID-19 vaccinations with AstraZeneca, awaits WHO reviewIndonesia will delay the administering of AstraZeneca’s COVID-19 vaccine due to reports of blood clots among some recipients in Europe and would await ... Coronavirus
Indonesia’s vaccination drive lags behind as COVID-19 cases surgeIndonesian President Joko Widodo received the nation’s first coronavirus vaccine live on television last month, but despite the fanfare, his ambitious ... Coronavirus
Indonesia satisfied with effectiveness of Chinese COVID-19 vaccineIndonesia’s government says it is satisfied with the effectiveness of the Chinese coronavirus vaccine it has been using, after China’s top disease ... Coronavirus